Hirsch Warren bought PRPH
March 17, 2024 · Form 4 insider transaction
Hirsch Warren bought 70,000 shares of ProPhase Labs, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
70,000
Price
$0.00
Total value
N/A
InsiderHirsch Warren
Role—
CompanyProPhase Labs, Inc. (PRPH)
SecurityOption (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 17, 2024
Filing dateMarch 19, 2024
Shares owned after70,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date.